Skip to search.
 TSX Up 2.88% TSX Ventures Up 2.99%

Geron Corporation (GERN)

-NasdaqGS
3.08 Up 0.03(0.98%) 4:00PM EDT
|After Hours : 3.08 0.00 (0.00%) 4:43PM EDT
Add to Portfolio
Prev Close:3.05
Open:3.08
Bid:2.93 x 1500
Ask:N/A
1y Target Est:5.50
Beta:1.48273
Earnings Date:Nov 2 - Nov 6 (Est.)
Day's Range:2.99 - 3.16
52wk Range:1.76 - 4.67
Volume:1,972,204
Avg Vol (3m):2,331,820
Market Cap:487.08M
P/E (ttm):N/A
EPS (ttm):-0.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNUp 0.98%487.08M
BMYUp 1.32%101.42B
GSKUp 1.83%99.60B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):428.36
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.12
Quarterly EPS Est (Sep-15) :0.11
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-4.97

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback